Acadia Pharma soars after favorable court ruling in patent dispute

Acadia Pharmaceuticals

16/05/2025 17:09

** Shares of drug developer Acadia Pharmaceuticals ACAD.O rise 34.2% to over 1-year high of $23.61

** U.S. District Court for the District of Delaware has ruled that India's Aurobindo Pharma infringes on two of Acadia Pharmaceuticals' patent claims

** The court has rejected Aurobindo's arguments that they are invalid

** The companies will meet to discuss next steps and submit a joint letter to the court within 21 days

** Acadia will provide an update on its revised stipulation regarding the patent claims within 7 days

** Companies must work together to redact sensitive information from the court's opinion and submit a proposed redacted version within 30 days

** Including session's move, stock up 28.3% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))